CN211023498U - Hydrocolloid sterile plaster - Google Patents
Hydrocolloid sterile plaster Download PDFInfo
- Publication number
- CN211023498U CN211023498U CN201921492868.2U CN201921492868U CN211023498U CN 211023498 U CN211023498 U CN 211023498U CN 201921492868 U CN201921492868 U CN 201921492868U CN 211023498 U CN211023498 U CN 211023498U
- Authority
- CN
- China
- Prior art keywords
- hydrocolloid
- layer
- absorbent pad
- sterile
- connect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The utility model discloses an aseptic applying ointment or plaster of hydrocolloid, include: the hydrocolloid absorbent pad, set up release paper under hydrocolloid absorbent pad, connect the medical pressure sensitive adhesive on hydrocolloid absorbent pad, connect the polyurethane film on medical pressure sensitive adhesive, connect the supporting layer on polyurethane film. The utility model discloses can absorb the sepage fast, the aseptic of preventing leakage is applied ointment or plaster, and laminating skin surface forms airtight environment for the surface of a wound healing.
Description
Technical Field
The utility model relates to the field of medical equipment, especially a sterile application of hydrocolloid.
Background
The traditional sterile application is medical absorbent gauze which is mainly used for hemostasis, and the water absorption pad of the existing sterile application product is a non-woven fabric absorption pad which only can play a role in absorbing wound exudate; the pure absorption of seepage cannot meet the market demand.
Hydrocolloid dressings are those made by processing a mixture of an elastic polymeric hydrogel with synthetic rubber and an adhesive. The most common gel in dressings is hydroxymethyl cellulose, which can be firmly adhered to the skin at the edge of a wound and can swell 12 times when imbibed with exudate.
Hydrocolloid dressings have the following properties: has the ability of absorbing wound exudate. After imbibing exudate, the hydrophilic particles in the dressing can form a gel-like semisolid substance which is attached to the base of a wound to provide and maintain a wet environment which is beneficial to wound healing. It has viscosity and can form an airtight (occlusive) wound surface. The closed healing environment can promote the proliferation of capillary vessels and the formation of granulation tissues, thereby accelerating the healing of the wound surface. Can play the function of debridement. On the one hand, the hydrocolloid contains endogenous enzymes and can promote the dissolution of fibrin; on the other hand, the closed environment provided by the hydrocolloid dressing is beneficial to macrophage to remove necrotic tissues.
The market needs a sterile application that can quickly absorb the seepage and prevent leakage, and the utility model solves the problems.
SUMMERY OF THE UTILITY MODEL
For solving prior art's not enough, the utility model aims to provide a sterile application of hydrocolloid can the rapid absorption sepage, prevents the aseptic application of plaster of leakage, and laminating skin surface forms airtight environment for the surface of a wound healing.
In order to achieve the above object, the utility model adopts the following technical scheme:
hydrocolloid sterile dressings comprising: the hydrocolloid absorbent pad, set up release paper under hydrocolloid absorbent pad, connect the medical pressure sensitive adhesive on hydrocolloid absorbent pad, connect the polyurethane film on medical pressure sensitive adhesive, connect the supporting layer on polyurethane film.
The aseptic applying ointment or plaster of aforesaid hydrocolloid, hydrocolloid absorbent pad are constituteed and are had: the water absorption non-woven fabric is compounded on a first hydrocolloid layer at the lower end of the water absorption non-woven fabric, and a second hydrocolloid layer at the lower end of the first hydrocolloid layer, and the area of the first hydrocolloid layer is larger than that of the second hydrocolloid layer.
In the aseptic hydrocolloid application, the thickness of the second hydrocolloid layer is 0.1-0.4 mm.
The aseptic application of aforesaid hydrocolloid, first hydrocolloid layer constitution has: the first hydrocolloid body is arranged on two sides of the first hydrocolloid body and is provided with an inclined extending block for preventing liquid leakage.
In the aforementioned hydrocolloid aseptic application, the inclined extension blocks comprise: the blocking protrusion inclined to the first hydrocolloid body is arranged on the edge of the blocking protrusion and is attached to the hydrocolloid slice of the skin.
The hydrocolloid aseptic patch has a thickness of 0.03-0.06 mm.
In the aseptic application of hydrocolloid, the thickness of the first hydrocolloid body is 0.1-0.4 mm.
The hydrocolloid aseptic patch has a water-absorbent non-woven fabric thickness of 0.3-0.6 mm.
The utility model discloses an useful part lies in:
the two layers of hydrocolloid can quickly absorb seepage liquid and prevent leakage;
the design of the inclined extension block of the first hydrocolloid layer can avoid the liquid absorption speed from being not fast enough, so that the liquid leaks;
the design of the hydrocolloid slice can ensure that the application further fits the surface of the skin to form a closed environment, and the healing of the wound surface is accelerated.
Drawings
Fig. 1 is a schematic structural view of an embodiment of the hydrocolloid absorbent pad of the present invention;
fig. 2 is a cross-sectional view of an embodiment of the present invention;
fig. 3 is a schematic structural diagram of an embodiment of the release paper frame of the present invention.
The meaning of the reference symbols in the figures:
1 hydrocolloid absorbent pad, 11 absorbent nonwoven, 12 first hydrocolloid layers, 121 first hydrocolloid body, 122 slope extension piece, 1221 blocks the arch, 1222 hydrocolloid sheet, 13 second hydrocolloid layers, 2 from type paper, 3 medical pressure sensitive adhesive, 4 polyurethane film, 5 supporting layers, 6 paper frame type from type paper, 601 from type paper frame, 602 writing sticky tape.
Detailed Description
The present invention will be described in detail with reference to the accompanying drawings and specific embodiments.
Hydrocolloid sterile dressings comprising: hydrocolloid absorbent pad 1 sets up release paper 2 under hydrocolloid absorbent pad 1, connects medical pressure sensitive adhesive 3 on hydrocolloid absorbent pad 1, connects polyurethane film 4 on medical pressure sensitive adhesive 3, connects supporting layer 5 on polyurethane film 4. As an example, the thickness of the water-absorbent nonwoven fabric 11 is 0.3 to 0.6 mm.
As shown in fig. 1, the hydrocolloid absorbent pad 1 is composed of: the water absorption non-woven fabric 11, compound in the first hydrocolloid layer 12 of the non-woven fabric 11 lower extreme that absorbs water, compound in the second hydrocolloid layer 13 of the first hydrocolloid layer 12 lower extreme, the area of first hydrocolloid layer 12 is greater than second hydrocolloid layer 13. As an example, the thickness of the second hydrocolloid layer 13 is 0.1-0.4 mm. The two layers of hydrocolloid can quickly absorb seepage to prevent leakage.
The first hydrocolloid layer 12 consists of: a first hydrocolloid body 121, an inclined extension 122 disposed at both sides of the first hydrocolloid body 121 and preventing liquid leakage; the inclined extension 122 is composed of: a blocking protrusion 1221 inclined to the first hydrocolloid body 121, and a hydrocolloid sheet 1222 disposed at an edge of the blocking protrusion 1221 and attached to the skin. As an example, the thickness of the hydrocolloid sheet 1222 is 0.03-0.06mm, and the thickness of the first hydrocolloid body 121 is 0.1-0.4 mm. The design of the inclined extension 122 of the first hydrocolloid layer 12 makes it possible to avoid the liquid absorption rate being not fast enough for the liquid to leak; the hydrocolloid sheet 1222 is designed to allow the patch to further conform to the skin surface to form a closed environment, thereby accelerating wound healing.
The support layer 5 includes: a paper frame type release paper 6 and a polyethylene film.
As shown in fig. 3, the paper frame type release paper 6 comprises: a release paper frame 601, a writing adhesive tape 602 located on the release paper frame 601; such a design facilitates writing indicia.
As an example, the supporting layer 5 is a paper frame type release paper 6; the production process of the product comprises the following steps: cutting 1-1.5mm hydrocolloid obtained from a supplier into a first hydrocolloid layer 12, and cutting a hydrocolloid sheet 1222 at the edge of the first hydrocolloid layer 12 by using a fine cutting machine to obtain the first hydrocolloid layer 12; and cutting a second hydrocolloid layer 13 with the thickness of 0.1-0.4mm, and thermally compounding the second hydrocolloid layer and the water-absorbent non-woven fabric 11 to obtain the hydrocolloid water absorbent pad 1. Compounding paper frame type release paper 6 with a polyurethane film 4 and a medical pressure-sensitive adhesive 3, then slitting and forming, after windowing, adding water colloid water absorption pads 1 into release paper 2, performing die cutting and forming after compounding release, and then performing paper-plastic packaging and printing date batch numbers; packaging after inspection, sterilizing with ethylene oxide, inspecting and warehousing.
As an example, the support layer 5 is a polyethylene film; the production process of the product comprises the following steps: cutting 1-1.5mm hydrocolloid obtained from a supplier into a first hydrocolloid layer 12, and cutting a hydrocolloid sheet 1222 at the edge of the first hydrocolloid layer 12 by using a fine cutting machine to obtain the first hydrocolloid layer 12; and cutting a second hydrocolloid layer 13 with the thickness of 0.1-0.4mm, and thermally compounding the second hydrocolloid layer and the water-absorbent non-woven fabric 11 to obtain the hydrocolloid water absorbent pad 1. Cutting and forming a polyethylene film, a polyurethane film 4 and a medical pressure-sensitive adhesive 3, peeling, adding a hydrocolloid water absorption pad 1, compounding release paper 2, then die-cutting and forming, and then carrying out paper-plastic packaging and date batch number printing; packaging after inspection, sterilizing with ethylene oxide, inspecting and warehousing.
The foregoing illustrates and describes the principles, general features, and advantages of the present invention. It should be understood by those skilled in the art that the above embodiments do not limit the present invention in any way, and all technical solutions obtained by adopting equivalent replacement or equivalent transformation fall within the protection scope of the present invention.
Claims (8)
1. Hydrocolloid aseptic application characterized in that, includes: hydrocolloid absorbent pad, set up in hydrocolloid absorbent pad is lower from the type paper, connect in medical pressure sensitive adhesive on hydrocolloid absorbent pad, connect in polyurethane film on the medical pressure sensitive adhesive, connect in supporting layer on the polyurethane film.
2. Hydrocolloid sterile dressing according to claim 1, characterized in that the hydrocolloid absorbent pad consists of: the water-absorbing non-woven fabric comprises a water-absorbing non-woven fabric, a first hydrocolloid layer compounded at the lower end of the water-absorbing non-woven fabric, and a second hydrocolloid layer compounded at the lower end of the first hydrocolloid layer, wherein the area of the first hydrocolloid layer is larger than that of the second hydrocolloid layer.
3. Hydrocolloid sterile dressing according to claim 2, characterized in that the thickness of the second hydrocolloid layer is 0.1-0.4 mm.
4. Hydrocolloid sterile dressing according to claim 2, characterized in that the first hydrocolloid layer consists of: the first hydrocolloid body is arranged on two sides of the first hydrocolloid body and is provided with an inclined extending block for preventing liquid leakage.
5. Sterile application of hydrocolloids according to claim 4, characterised in that the inclined extensions consist of: the barrier protrusion is inclined to the first hydrocolloid body, and the hydrocolloid sheet is arranged on the edge of the barrier protrusion and is attached to the skin.
6. Hydrocolloid sterile dressing according to claim 5, characterized in that the thickness of the hydrocolloid sheet is 0.03-0.06 mm.
7. Hydrocolloid sterile application according to claim 4, characterized in that the first hydrocolloid body has a thickness of 0.1-0.4 mm.
8. Hydrocolloid sterile dressing according to claim 2, characterized in that the thickness of the water-absorbent nonwoven is 0.3-0.6 mm.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921492868.2U CN211023498U (en) | 2019-09-09 | 2019-09-09 | Hydrocolloid sterile plaster |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201921492868.2U CN211023498U (en) | 2019-09-09 | 2019-09-09 | Hydrocolloid sterile plaster |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN211023498U true CN211023498U (en) | 2020-07-17 |
Family
ID=71562333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201921492868.2U Active CN211023498U (en) | 2019-09-09 | 2019-09-09 | Hydrocolloid sterile plaster |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN211023498U (en) |
-
2019
- 2019-09-09 CN CN201921492868.2U patent/CN211023498U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5112618A (en) | Hydrogel wound dressing product | |
| US5059424A (en) | Hydrogel wound dressing product | |
| US6566575B1 (en) | Patterned absorbent article for wound dressing | |
| AU2012314476B2 (en) | Improved wound dressing | |
| US20120220973A1 (en) | Adhesive bandage | |
| US20120220975A1 (en) | Adhesive bandage | |
| AU2016254448B2 (en) | Wound dressing | |
| EP0411063B1 (en) | Wound dressing | |
| GB2526267A (en) | Dressing for surgical drain | |
| CN103876895A (en) | Liquid absorption wound dressing enabling wound surface to be observable | |
| GB2525494A (en) | Wound dressing | |
| CN111481346A (en) | Silica gel plaster and use method and application thereof | |
| CN212234953U (en) | Silica gel is applied ointment or plaster | |
| CN211023498U (en) | Hydrocolloid sterile plaster | |
| JP2002000639A (en) | Pad for first-aid adhesive tape and first-aid adhesive tape using the same | |
| CN204072475U (en) | A kind of composite aquogel wound dressing | |
| CN211705032U (en) | Novel anti-adhesion dressing | |
| CN212547387U (en) | Combined dressing capable of reducing replacement times | |
| CN218279959U (en) | Novel polyurethane foam dressing | |
| CN111821101A (en) | Combined dressing capable of reducing replacement times | |
| CN211023497U (en) | Polyurethane cotton sterile plaster | |
| CN212730158U (en) | Foam dressing with humidity indication function | |
| CN211024320U (en) | Aseptic application of chitosan | |
| CN211512803U (en) | Non-woven liquid absorption pad | |
| CN216876817U (en) | Improved sterile plaster |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |